Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 510,445 | 555,030 | 482,374 | 1,074,036 | 716,782 |
| Marketable Securities | 919,602 | 878,796 | 298,073 | 74,244 | N/A |
| Receivables | 140,857 | 52,012 | 41,189 | 29,713 | 24,351 |
| Inventories | 132,068 | 98,578 | 83,248 | 69,922 | 67,009 |
| TOTAL | $1,794,208 | $1,621,661 | $929,063 | $1,273,383 | $837,040 |
| Non-Current Assets | |||||
| PPE Net | 102,942 | 80,052 | 65,384 | 56,491 | 52,955 |
| Investments And Advances | 0 | 0 | 0 | 0 | 50,043 |
| Intangibles | 233,761 | 194,762 | 199,814 | 204,866 | 209,919 |
| Other Non-Current Assets | 133,647 | 128,756 | 135,576 | 121,695 | 93,551 |
| TOTAL | $470,350 | $403,570 | $400,774 | $383,052 | $406,468 |
| Total Assets | $2,264,558 | $2,025,231 | $1,329,837 | $1,656,435 | $1,243,508 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 456,060 | 285,209 | 214,987 | 182,117 | 125,030 |
| TOTAL | $468,874 | $297,528 | $225,629 | $190,243 | $135,166 |
| Non-Current Liabilities | |||||
| Long Term Debt | 540,964 | 1,103,382 | 1,155,313 | 1,125,250 | 566,588 |
| Other Non-Current Liabilities | 495,025 | 314,878 | 253,792 | 223,355 | 117,183 |
| TOTAL | $1,056,708 | $1,442,324 | $1,436,131 | $1,378,241 | $697,874 |
| Total Liabilities | $1,525,582 | $1,739,852 | $1,661,760 | $1,568,484 | $833,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 215,552 | 180,999 | 148,492 | 136,405 | 118,905 |
| Common Shares | 2,143 | 1,794 | 1,480 | 1,357 | 1,187 |
| Retained earnings | -5,636,692 | -4,359,917 | -3,446,145 | -2,696,578 | -2,265,243 |
| Other shareholders' equity | 1,461 | -2,289 | -745 | 756 | 968 |
| TOTAL | $738,976 | $285,379 | $-331,923 | $87,951 | $410,468 |
| Total Liabilities And Equity | $2,264,558 | $2,025,231 | $1,329,837 | $1,656,435 | $1,243,508 |